Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site by CNBC Markets | December 1, 2025 7:24 pm | US Markets The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.
